Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APG-115 + Toripalimab in Advanced Liposarcoma and Solid Tumors
NCT04785196Phase 2Recruiting
- Sponsor
- Ascentage Pharma
- Start
- May 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alrizomadlin in Liposarcoma, solid tumor (advanced stage), sponsored by Ascentage Pharma. Started May 2021; status: recruiting.
02
Drugs
alrizomadlin
03
Conditions
Liposarcomasolid tumor (advanced stage)
Beyond the preview
Go deeper on NCT04785196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04785196.